Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.
about
Acute Kidney Injury in Patients with CirrhosisHepatorenal syndrome: Update on diagnosis and treatmentOutcomes of liver transplantation in patients with hepatorenal syndromeBiomarkers in chronic kidney disease, from kidney function to kidney damageCombining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure.Update on cystatin C: incorporation into clinical practice.Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failureImmunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options.Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis.Benefit of cystatin C in evaluation of renal function and prediction of survival in patients with cirrhosis.Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis
P2860
Q26775643-274DB215-1EF9-4C3E-946C-AC724B315337Q26777608-171537C7-1821-4AE3-90F4-87E34793263FQ28068506-F747F95E-E735-43E0-8525-A8C8D29899D0Q28087304-EC4D5937-8452-4319-80AB-B96AD2357004Q35023406-0D75BFCA-769B-496D-B34F-7930890CC686Q37126287-AB259DDF-6680-4670-B5E6-A7CD8EFBA691Q37440014-0F927B33-DDCF-47E8-8CE5-35E1A0F486E6Q38383495-9BCC650D-CD81-4375-9937-E7C4CA97A5E8Q38654403-50FA1DA3-84F2-4172-9174-8B6F5D3895F0Q38763423-DEA92D36-1A6C-4531-A89D-086C1D8C9094Q50956314-FFA30686-9DC4-4855-B87C-58015E66D4A1Q56925226-56352A8A-1C1B-41E3-B375-E7FB6843AE56
P2860
Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.
@en
Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.
@nl
type
label
Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.
@en
Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.
@nl
prefLabel
Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.
@en
Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.
@nl
P2093
P2860
P1476
Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.
@en
P2093
Ahmed Ali Mohammed
Eglal M Shawky
Hatem A Hassan
Lamia H Ali
Mohammed A Sharawey
Yasser M Fouad
P2860
P2888
P356
10.1007/S12072-011-9266-Y
P577
2011-03-12T00:00:00Z